Home > Category > Chiral Reagent > (5aR,10bS)-5a,10b-Dihydro-2-((2,6-dibromo-4-trifluoromethyl)phenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate

(5aR,10bS)-5a,10b-Dihydro-2-((2,6-dibromo-4-trifluoromethyl)phenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate

Daicel≥98%,99%e.e.

Catalog No：200949-100MG CAS No.：NA MDLNo： Brand:Daicel purity：≥98%,99%e.e. 特性： Purpose:

Share

Size	Availability	Price(USD)
100MG	请咨询	$1775.00

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry

Product Overview
Related documents
Related literature

Product Overview

Product Name	(5aR,10bS)-5a,10b-Dihydro-2-((2,6-dibromo-4-trifluoromethyl)phenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate
CAS	NA
Formula	C₁₉H₁₃F₃Br₂N₃O·BF₄

Related literature

Sorry, there is no relevant literature

Related

(4S,4'S)-2,2'-(1-Phenylpropane-2,2-diyl)bis(4,5,5-triphenyl-4,5-dihydrooxazole)

(4S,4'S)-2,2'-(1-Phenylpropane-2,2-diyl)bis(4,5,5-triphenyl-4,5-dihydrooxazole)

2409652-68-0 ≥95%,-

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1639447-03-2 ≥95%,-

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1639447-03-2 ≥95%,-

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1639447-03-2 ≥95%,-

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1,1'-[(1S)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

1,1'-[(1S)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

1,1'-[(1R)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

1,1'-[(1R)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

(S)-2,2'-Bis(diisopropylphosphanyl)-1,1'-binaphthalene

(S)-2,2'-Bis(diisopropylphosphanyl)-1,1'-binaphthalene

History

(5aR,10bS)-5a,10b-Dihydro-2-((2,6-dibromo-4-trifluoromethyl)phenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate

(5aR,10bS)-5a,10b-Dihydro-2-((2,6-dibromo-4-trifluoromethyl)phenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate

NA ≥98%,99%e.e.

IHVR-19029

(11aS)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

(11aS)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

NA ≥95%,99%e.e.

BMVC-8C3O

GSK-3484862

[S(R)]-N-[(R)-[2-(Diphenylphosphino)phenyl](4-methoxyphenyl)methyl]-2-methyl-2-propanesulfinamide

[S(R)]-N-[(R)-[2-(Diphenylphosphino)phenyl](4-methoxyphenyl)methyl]-2-methyl-2-propanesulfinamide

1595319-96-2 ≥95%,-